The global Semaglutide Market has gained remarkable attention due to the rising prevalence of metabolic disorders such as type 2 diabetes and obesity across both developed and emerging economies. Semaglutide, a GLP-1 receptor agonist, has transformed treatment paradigms by offering improved glycemic control, sustained weight reduction, and cardiovascular benefits. Growing awareness among...